| Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations. | |
| | |
MedLine Citation:
|
PMID: 19968966 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The heme peroxidase enzyme myeloperoxidase (MPO) is released by activated neutrophils and monocytes, where it uses hydrogen peroxide (H(2)O(2)) to catalyze the production of the potent oxidants hypochlorous acid (HOCl), hypobromous acid (HOBr) and hypothiocyanous acid (HOSCN) from halide and pseudohalide (SCN(-)) ions. These oxidants have been implicated as key mediators of tissue damage in many human inflammatory diseases including atherosclerosis, asthma, rheumatoid arthritis, cystic fibrosis and some cancers. It is shown here that acetaminophen (paracetamol), a phenol-based drug with analgesic and antipyretic actions, is an efficient inhibitor of HOCl and HOBr generation by isolated MPO-H(2)O(2)-halide systems. With physiological halide concentrations, acetaminophen concentrations required for 50% inhibition of oxidant formation (IC(50)) were 77+/-6microM (100mMCl(-)) and 92+/-2microM (100mMCl(-) plus 100microMBr(-)), as measured by trapping of oxidants with taurine. The IC(50) for inhibition of HOCl generation by human neutrophils was ca. 100microM. These values are lower than the maximal therapeutic plasma concentrations of acetaminophen (< or =150microM) resulting from typical dosing regimes. Acetaminophen did not diminish superoxide generation by neutrophils, as measured by lucigenin-dependent chemiluminescence. Inhibition of HOCl production was associated with the generation of fluorescent acetaminophen oxidation products, consistent with acetaminophen acting as a competitive substrate of MPO. Inhibition by acetaminophen was maintained in the presence of heparan sulfate and extracellular matrix, materials implicated in the sequestration of MPO at sites of inflammation in vivo. Overall, these data indicate that acetaminophen may be an important modulator of MPO activity in vivo. |
| | |
Authors:
|
Maud Koelsch; Roger Mallak; Garry G Graham; Tracey Kajer; Marian K Milligan; Ly Q Nguyen; Dawn W Newsham; Jeremy S Keh; Anthony J Kettle; Kieran F Scott; John B Ziegler; David I Pattison; Shanlin Fu; Clare L Hawkins; Martin D Rees; Michael J Davies |
Related Documents
:
|
11549446 - Modulation of human mammary cell sensitivity to paclitaxel by new quinoline sulfonamides. 14998586 - Synthesis and aldose reductase inhibitory activities of novel thienocinnolinone derivat... 18087806 - Antioxidant and antiatherogenic activity of cis-hinokiresinol from trapa pseudoincisa. 17329866 - Inhibition of chitin synthases and antifungal activities by 2'-benzoyloxycinnamaldehyde... 21550666 - Friedreich's ataxia: past, present and future. 19109676 - Synthesis of (-)-pericosine b, the antipode of the cytotoxic marine natural product. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-12-05 |
Journal Detail:
|
Title: Biochemical pharmacology Volume: 79 ISSN: 1873-2968 ISO Abbreviation: Biochem. Pharmacol. Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-02-17 Completed Date: 2010-03-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0101032 Medline TA: Biochem Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 1156-64 Citation Subset: IM |
Copyright Information:
|
2009 Elsevier Inc. All rights reserved. |
Affiliation:
|
Heart Research Institute, Newtown, Sydney, NSW, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetaminophen
/
pharmacology* Analgesics, Non-Narcotic / pharmacology* Bromates / metabolism, toxicity Catalysis Humans Hypochlorous Acid / metabolism, toxicity Neutrophils / drug effects, metabolism Oxidants / metabolism*, toxicity Peroxidase / antagonists & inhibitors* Superoxides / metabolism |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Non-Narcotic; 0/Bromates; 0/Oxidants; 103-90-2/Acetaminophen; 11062-77-4/Superoxides; 13517-11-8/hypobromous acid; 7790-92-3/Hypochlorous Acid; EC 1.11.1.7/Peroxidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular en...
Next Document: Changes in NPY and POMC, but not serotonin transporter, following a restricted feeding/repletion pro...